EVO

About Evotec SE American Depositary Shares (EVO) Stock

Evotec SE American Depositary Shares (EVO) closed the 2026-09-18 session at $1.60, down 4.19% versus the previous close (-0.07). The stock opened at $1.74 and traded between $1.57 and $1.75 during that session. Session trading volume was 1.4M shares. The volume-weighted average price (VWAP) is $1.63.

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Evotec SE American Depositary Shares has a market capitalization of $593.5 million. EVO is listed on the XNAS exchange. The company employs approximately 4,553 people. The recorded listing date is 1999-06-02.

On this page you can find market EVO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.